Your browser doesn't support javascript.
loading
A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome.
Wolf, Elizabeth R; Tong, Sebastian T; Sabo, Roy T; Woolf, Steven H; Abbinanti, Kassie; Pecsok, James; Krist, Alex H.
Afiliação
  • Wolf ER; Department of Pediatrics, Virginia Commonwealth University, 1000 East Broad Street, Richmond, VA, 23219, USA. elizabeth.wolf@vcuhealth.org.
  • Tong ST; Children's Hospital of Richmond at VCU, Richmond, VA, USA. elizabeth.wolf@vcuhealth.org.
  • Sabo RT; Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, VA, USA.
  • Woolf SH; Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, VA, USA.
  • Abbinanti K; Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA.
  • Pecsok J; Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, VA, USA.
  • Krist AH; Center on Society and Health, Richmond, VA, USA.
BMC Pediatr ; 19(1): 371, 2019 10 23.
Article em En | MEDLINE | ID: mdl-31640614
BACKGROUND: Adult opioid use and neonatal abstinence syndrome (NAS) are growing public health problems in the United States (U.S.). Our objective was to determine how opioid use disorder treatment access impacts the relationship between adult opioid use and NAS. METHODS: We conducted a cross-sectional state-level ecologic study using 36 states with available Healthcare Cost and Utilization Project State Inpatient Databases in 2014. Opioid use disorder treatment access was determined by the: 1) proportion of people needing but not receiving substance use treatment, 2) density of buprenorphine-waivered physicians, and 3) proportion of individuals in outpatient treatment programs (OTPs). The incidence of NAS was defined as ICD-9 code 779.5 (drug withdrawal syndrome in newborn) from any discharge diagnosis field per 1000 live births in that state. RESULTS: Unmet need for substance use disorder treatment correlated with NAS (r = 0.54, 95% CI: 0.26-0.73). The correlation between adult illicit drug use/dependence and NAS was higher in states with a lower density of buprenorphine-waivered physicians and individuals in OTPs. CONCLUSIONS: Measures of opioid use disorder treatment access dampened the correlation between illicit drug use/dependence and NAS. Future studies using community- or individual-level data may be better poised to answer the question of whether or not opioid use disorder treatment access improves NAS relative to adult opioid use.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Síndrome de Abstinência Neonatal / Acessibilidade aos Serviços de Saúde / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Síndrome de Abstinência Neonatal / Acessibilidade aos Serviços de Saúde / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article